Journal of Biomedical Science and Engineering

Volume 3, Issue 5 (May 2010)

ISSN Print: 1937-6871   ISSN Online: 1937-688X

Google-based Impact Factor: 0.66  Citations  h5-index & Ranking

Determination of isotretinoin in pharmaceutical formulations by reversed-phase HPLC

HTML  Download Download as PDF (Size: 447KB)  PP. 454-458  
DOI: 10.4236/jbise.2010.35063    8,642 Downloads   17,087 Views  Citations

Affiliation(s)

.

ABSTRACT

The development of facile and rapid quantification of biologically active biomolecules such as isotretitoin in therapeutic drugs contained in many generic formu- lations is necessary for determining their efficiency and their quality to improve the human health care. Isotretritoin finds its applications in the maintenance of epithelial tissues. Different processes to date such as normal phase HPLC, or gas chromatrography am- ong others are able to separate and quantify isote- troin. However, the extraction is quite complex and in the case of HPLC, the analysis requires long retention times. In such context, an isocratic reversed- phase high-performance liquid chromatography (HP- LC) technique coupled with an UV-vis detector is described here for easy separation and quantification of 13-cis-retinoic (isotretinoin) from soft gelatin capsule formulations. The isotretinoin was extracted from three different commercial drug samples with tetrahydrofuran (THF) solvent by a procedure that can be completed in less than 10 minutes. Subsequent separation and quantification were accomplished in less than 5 minutes under isocratic reversed-phase conditions on a Lichrospher RP18 column and a mobile phase consisting of 0.01% TFA/acetonitrile (15/85, v/v) at a flow rate of 1.0 mL/min. Isotretoin was detected for the three samples via its UV-vis absorbance at 342 nm. The method was validated and the results showed good linearity, precision and accuracy for sensitive and selective quantitative determination of isotretinoin in the different pharmaceutical formulations. We found that the average isotretinoin content in two of the three commercial pro- ducts fell outside the 90-110% United States Pha- rmacopeia specifications. Consequently, the facile extraction and the precise method for the biomole- cule quantification open up tremendous possibilities in improving the quality control of drugs which can exist as different generic brands.

Share and Cite:

Guimaraes, C. , Menaa, F. , Menaa, B. , Lebrun, I. , Quenca-Guillen, J. , Auada, A. , Mercuri, L. , Ferreira, P. and Santoro, M. (2010) Determination of isotretinoin in pharmaceutical formulations by reversed-phase HPLC. Journal of Biomedical Science and Engineering, 3, 454-458. doi: 10.4236/jbise.2010.35063.

Cited by

[1] A review of HPLC technique covering its pharmaceutical, environmental, forensic, clinical and other applications
International Journal of Pharmaceutical Chemistry and Analysis, 2019
[2] Roaccutane (İzotretinoin) Kullanan Hastalarda vHIT Kullanılarak Vestibüler Sistem Değerlendirmesi
2019
[3] Development of a stability-indicating UPLC method for determination of isotretinoin in bulk drug
Pharmaceutical Development and Technology, 2018
[4] Turn-off fluorescence of amino-functionalized carbon quantum dots as effective fluorescent probes for determination of isotretinoin
Sensors and Actuators B: Chemical, 2017
[5] The kinetic study of isotretinoin release from nanoemulsion
Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2016
[6] TOPİKAL İZOTRETİNOİN UYGULAMASINA YÖNELİK KOLOİDAL İLAÇ TAŞIYICI SİSTEMLERİN GELİŞTİRİLMESİ
2014
[7] Serum lipids and liver enzymes in patients treated with oral isotretinoin
2013

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.